Center for Immunotherapy and Cell-Based Technologies

Novosibirsk — Kaliningrad — Moscow — Irkutsk
Main

Prostate cancer

Xenovaccinotherapy for cancer

http://www.medicalnewstoday.com/rss/cancer-oncology.xmlhttp://www.medicalnewstoday.com/rss/immune_system.xmlhttp://www.medicalnewstoday.com/rss/multiple_sclerosis.xmlhttp://www.medicalnewstoday.com/rss/stem_cell_research.xml

  • docid_2.pageCache.php

27.12.2018 A newly developed test can detect the risk of metastasis in people with prostate cancer at a quicker rate, lower cost, and using smaller tissue sample...

23.12.2018 By coating nanoparticles with gold, researchers have successfully destroyed prostate cancer cells in people without damaging surrounding tissue....

11.12.2018 Back pain is a common complaint with many possible causes. In some cases, chronic, unexplained back pain can occur with advanced prostate cancer. Lear...

06.12.2018 A prostatectomy is one treatment option for prostate cancer. It involves the surgical removal of the prostate gland. Following a prostatectomy, doctor...

05.12.2018 Doctors do not fully understand what causes prostate cancer. This disease may have an association with alcohol, but scientists need to do more researc...

30.09.2018 A systematic review of 71 studies suggests that regular aspirin intake may help treat cancers such as colon cancer, breast cancer, and prostate cancer...

16.08.2018 Age, genetics, and a poor diet are among the many risk factors for prostate cancer. By taking certain steps, a person may be able to reduce their risk...

30.07.2018 Creating a way to keep prostate cancer cells alive in the laboratory for longer leads to quicker drug trials. Sharing this widely speeds it up further...

18.06.2018 Research locates new genetic markers that may show an elevated risk of developing prostate cancer. This will help to identify men who need early scree...

06.06.2018 For the first time, a major clinical trial shows that immunotherapy can successfully treat very advanced forms of prostate cancer. ...


Immunotherapy for cancer

An active specific immunotherapy (vaccinotherapy) is a strategy using tumor-associated antigens for including antitumor immune responses. The small structural distinctions of the xenogenic tumor-associated antigens from their human analogues render these antigens highly immunogenic and capable of including immune-mediated, antitumor responses in a patient not only at early, but also at advanced stages of disease, when tumor-derived immunosuppression is significant. Tumor-specfic immunotherapy is able to generate a selective and long-term antitumor effect. Such a therapy has no complications attributable to chemotherapy.

Xenovaccinotherapy for cancer